Ocular Inflammation and Pain - Pipeline Insight, 2021

SKU ID : DEL-19306969 | Publishing Date : 12-Oct-2021 | No. of pages : 60

Detailed TOC of Ocular Inflammation and Pain - Pipeline Insight, 2021

Introduction
Executive Summary
Ocular Inflammation and Pain: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Late Stage Products (Phase III)
• Comparative Analysis
APP13007: Formosa pharmaceuticals
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
RX-10045: A.T. Resolve SARL
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Early stage products (Phase I/II)
• Comparative Analysis
Drug Name: Company Name
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Ocular Inflammation and Pain Key Companies
Ocular Inflammation and Pain Key Products
Ocular Inflammation and Pain- Unmet Needs
Ocular Inflammation and Pain- Market Drivers and Barriers
Ocular Inflammation and Pain- Future Perspectives and Conclusion
Ocular Inflammation and Pain Analyst Views
Ocular Inflammation and Pain Key Companies
Appendix

List of Figures, Tables and Charts Available in Ocular Inflammation and Pain - Pipeline Insight, 2021

Table 1 Total Products for Ocular Inflammation and Pain
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products